Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHumanized mAb against toll-like receptor 4 (TLR4)
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today